AXTI is trading 5.2% down at $106.97 as investors continue to assess the impact of a recent, large-scale capital raise and the associated share dilution.
- The move follows the completion of a roughly $632.5 million public offering, intended to fund the expansion of its indium phosphide substrate capacity to meet surging AI-related demand. [4, 5, 6, 11, 12]
- While the financing is aimed at capturing long-term growth, the near-term effect has been share dilution and significant price volatility, including a 14.5% decline on May 18 and a 6.6% recovery on May 19.
- Today's decline occurs as the market weighs the company's strong growth prospects in the AI sector against the dilutive impact of the recent stock offering. [4, 14]